Your browser is no longer supported. Please, upgrade your browser.
BLUE bluebird bio, Inc. monthly Stock Chart
BLUE [NASD]
bluebird bio, Inc.
Index- P/E- EPS (ttm)-10.98 Insider Own0.50% Shs Outstand66.25M Perf Week2.37%
Market Cap2.87B Forward P/E- EPS next Y-11.23 Insider Trans-1.57% Shs Float66.04M Perf Month-16.64%
Income-642.20M PEG- EPS next Q-2.93 Inst Own97.70% Short Float10.34% Perf Quarter-25.65%
Sales250.00M P/S11.48 EPS this Y-34.00% Inst Trans-2.13% Short Ratio7.82 Perf Half Y-32.30%
Book/sh22.99 P/B1.92 EPS next Y-13.80% ROA-35.10% Target Price- Perf Year-45.53%
Cash/sh18.89 P/C2.33 EPS next 5Y- ROE-45.80% 52W Range38.95 - 99.36 Perf YTD-49.75%
Dividend- P/FCF- EPS past 5Y-50.80% ROI-63.40% 52W High-55.63% Beta1.93
Dividend %- Quick Ratio6.60 Sales past 5Y11.90% Gross Margin98.00% 52W Low13.20% ATR2.08
Employees1171 Current Ratio6.60 Sales Q/Q116.90% Oper. Margin- RSI (14)37.80 Volatility2.68% 4.46%
OptionableYes Debt/Eq0.00 EPS Q/Q21.10% Profit Margin- Rel Volume1.05 Prev Close44.06
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume873.02K Price44.09
Recom2.00 SMA20-6.16% SMA50-15.23% SMA200-24.00% Volume914,381 Change0.07%
Nov-11-20Initiated Berenberg Buy
Nov-05-20Downgrade Stifel Buy → Hold $77 → $51
Nov-05-20Downgrade BMO Capital Markets Outperform → Market Perform $108 → $56
Nov-05-20Downgrade Barclays Overweight → Equal Weight
Nov-02-20Upgrade William Blair Mkt Perform → Outperform
Oct-20-20Initiated Mizuho Buy $123
May-13-20Initiated RBC Capital Mkts Outperform $100
Mar-27-20Upgrade Stifel Hold → Buy $70
Feb-19-20Downgrade Raymond James Strong Buy → Mkt Perform
Feb-19-20Downgrade Raymond James Outperform → Mkt Perform
Feb-03-20Upgrade Evercore ISI In-line → Outperform $86 → $100
Feb-03-20Resumed BofA/Merrill Buy $120
Dec-13-19Upgrade Oppenheimer Perform → Outperform $135
Nov-26-19Upgrade SVB Leerink Mkt Perform → Outperform $119
Nov-19-19Downgrade Evercore ISI Outperform → In-line $86
Nov-04-19Upgrade Wedbush Neutral → Outperform $131 → $124
Oct-01-19Initiated Stifel Hold $109
Aug-12-19Downgrade William Blair Outperform → Mkt Perform
Jun-18-19Upgrade Maxim Group Hold → Buy $160
May-15-19Downgrade Wedbush Outperform → Neutral $166 → $131
Nov-28-20 11:30PM  
Nov-24-20 08:00AM  
Nov-23-20 11:30PM  
Nov-21-20 11:12PM  
Nov-18-20 10:00PM  
Nov-16-20 09:26PM  
Nov-14-20 06:00PM  
Nov-11-20 10:04AM  
Nov-10-20 09:29PM  
08:00AM  
Nov-09-20 11:00AM  
Nov-07-20 08:08AM  
Nov-06-20 06:23AM  
Nov-05-20 04:16PM  
02:27PM  
12:07PM  
11:23AM  
10:11AM  
09:10AM  
07:54AM  
07:30AM  
Nov-04-20 06:35PM  
04:17PM  
04:05PM  
03:16PM  
Nov-03-20 09:08AM  
Oct-22-20 12:33PM  
Oct-20-20 11:55AM  
Oct-11-20 08:50AM  
Oct-04-20 06:27AM  
Oct-02-20 05:00AM  
Sep-28-20 08:00AM  
Sep-23-20 05:00AM  
Sep-22-20 04:22PM  
01:20PM  
06:59AM  
Sep-09-20 09:21PM  
06:09AM  
Sep-04-20 11:31AM  
Sep-02-20 08:00AM  
Aug-29-20 06:30AM  
Aug-17-20 07:00AM  
Aug-12-20 07:22AM  
Aug-11-20 07:01AM  
Aug-06-20 11:42AM  
Aug-05-20 08:25PM  
04:10PM  
08:41AM  
Jul-31-20 08:00AM  
Jul-30-20 12:33PM  
Jul-29-20 04:16PM  
Jul-25-20 11:52AM  
Jul-13-20 01:41PM  
Jul-07-20 12:08PM  
Jul-01-20 08:31AM  
Jun-23-20 08:39AM  
Jun-22-20 04:35PM  
Jun-18-20 02:28AM  
Jun-16-20 06:30AM  
Jun-12-20 01:49PM  
05:30AM  
05:30AM  
Jun-11-20 06:55AM  
Jun-10-20 11:30AM  
Jun-08-20 01:25AM  
Jun-05-20 05:35AM  
Jun-04-20 04:01PM  
Jun-03-20 04:05PM  
May-28-20 08:00AM  
May-27-20 10:35AM  
May-25-20 12:00PM  
May-22-20 11:10AM  
May-19-20 06:53PM  
07:19AM  
May-18-20 09:32PM  
02:54PM  
07:08AM  
07:00AM  
May-15-20 09:01AM  
May-14-20 09:00AM  
May-13-20 05:00PM  
10:41AM  
09:54AM  
07:45AM  
06:59AM  
May-12-20 01:40PM  
May-11-20 12:01PM  
11:22AM  
09:44AM  
08:25AM  
07:35AM  
07:00AM  
May-08-20 09:55AM  
07:30AM  
Apr-30-20 06:27AM  
Apr-29-20 08:00AM  
Apr-28-20 12:44PM  
Apr-20-20 08:51AM  
Apr-05-20 09:02PM  
Apr-03-20 06:34PM  
bluebird bio, Inc., a biotechnology company, engages in researching, developing, and commercializing of transformative gene therapies for severe genetic diseases and cancer. Its gene therapy programs include LentiGlobin for the treatment of -thalassemia and sickle cell disease; and Lenti-D for the treatment of cerebral adrenoleukodystrophy. The company's product candidates in oncology include bb2121 and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has a strategic collaboration with Bristol-Myers Squibb to discover, develop, and commercialize disease-altering gene therapies in oncology; and Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize various immune cell therapies for cancer. The company also has collaborations with Medigene AG to discover T cell receptor (TCR) product candidates in the field of cancer; Gritstone Oncology, Inc. to discover TCR product candidates in the field of cancer; TC BioPharm Limited to research and develop gamma delta CAR T cells directed at hematologic and solid tumor targets; Forty Seven, Inc. to pursue clinical proof-of-concept for an antibody-based conditioning regimen; and Novo Nordisk A/S to develop in vivo genome editing treatments for genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leschly NickPresident and CEONov 02Sale52.9444423,50698,135Nov 04 04:04 PM
Davidson DavidChief Medical OfficerNov 02Sale52.94633,33539,640Nov 04 04:05 PM
Gregory Philip DChief Scientific OfficerNov 02Sale52.93593,12335,865Nov 04 04:05 PM
Cole JasonChief Operating andNov 02Sale52.97371,96035,262Nov 04 04:05 PM
Smith-Farrell JoanneCOO, OncologyNov 02Sale52.97371,96021,976Nov 04 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerNov 02Sale52.99351,85526,993Nov 04 04:05 PM
Davidson DavidChief Medical OfficerOct 02Sale52.77643,37739,703Oct 06 04:06 PM
Gregory Philip DChief Scientific OfficerOct 02Sale52.77603,16635,924Oct 06 04:05 PM
Leschly NickPresident and CEOOct 02Sale52.7745023,74498,579Oct 06 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerOct 02Sale52.77361,90027,028Oct 06 04:05 PM
Smith-Farrell JoanneChief Business OfficerOct 02Sale52.77382,00522,013Oct 06 04:06 PM
Cole JasonChief Operating andOct 02Sale52.77382,00535,299Oct 06 04:06 PM
Davidson DavidChief Medical OfficerSep 03Sale58.60412,40339,767Sep 08 04:07 PM
Gregory Philip DChief Scientific OfficerSep 03Sale58.60583,39935,984Sep 08 04:08 PM
Cole JasonChief Operating andSep 03Sale58.60362,11035,337Sep 08 04:08 PM
Smith-Farrell JoanneChief Business OfficerSep 03Sale58.60362,11022,051Sep 08 04:08 PM
FINGER ALISON CECILYChief Commercial OfficerSep 03Sale58.60352,05127,063Sep 08 04:08 PM
Leschly NickPresident and CEOSep 03Sale58.6043125,25799,029Sep 08 04:07 PM
Smith-Farrell JoanneChief Business OfficerAug 25Sale58.9522513,26422,087Aug 27 05:11 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerAug 03Sale61.00825,0029,512Aug 05 04:06 PM
Smith-Farrell JoanneChief Business OfficerAug 03Sale60.48372,23822,312Aug 05 04:05 PM
Cole JasonChief Operating andAug 03Sale60.48372,23835,373Aug 05 04:05 PM
Leschly NickPresident and CEOAug 03Sale60.4944426,85699,460Aug 05 04:05 PM
Davidson DavidChief Medical OfficerAug 03Sale60.75422,55239,808Aug 05 04:06 PM
Gregory Philip DChief Scientific OfficerAug 03Sale60.49593,56936,042Aug 05 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerAug 03Sale60.49352,11727,098Aug 05 04:05 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJul 20Sale66.3859639,5629,594Jul 22 05:22 PM
Smith-Farrell JoanneChief Business OfficerJul 02Sale61.57382,34022,349Jul 07 05:17 PM
Leschly NickPresident and CEOJul 02Sale61.5744327,27799,904Jul 07 05:19 PM
Cole JasonChief Operating andJul 02Sale61.57382,34035,410Jul 07 05:18 PM
Davidson DavidChief Medical OfficerJul 02Sale61.57422,58639,850Jul 07 05:22 PM
Gregory Philip DChief Scientific OfficerJul 02Sale61.57593,63336,101Jul 07 05:15 PM
FINGER ALISON CECILYChief Commercial OfficerJul 02Sale61.57362,21727,133Jul 07 05:16 PM
Smith-Farrell JoanneChief Business OfficerJun 04Sale65.2317011,08922,387Jun 08 04:24 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJun 04Sale65.2315410,04510,190Jun 08 04:24 PM
Davidson DavidChief Medical OfficerJun 02Sale64.03422,68939,892Jun 04 05:44 PM
Cole JasonChief Operating andJun 02Sale64.03382,43335,448Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerJun 02Sale64.03372,36922,557Jun 04 05:44 PM
Gregory Philip DChief Scientific OfficerJun 02Sale64.03593,77836,160Jun 04 05:43 PM
FINGER ALISON CECILYChief Commercial OfficerJun 02Sale64.04352,24127,169Jun 04 05:44 PM
Leschly NickPresident and CEOJun 02Sale64.0444428,433100,347Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerMay 04Sale50.1723211,63922,594May 05 04:05 PM
Smith-Farrell JoanneChief Business OfficerApr 06Sale43.7358325,49521,393Apr 08 04:12 PM
Baird William D IIIChief Financial OfficerFeb 13Sale90.601,254113,61213,746Feb 18 07:14 PM
Gregory Philip DChief Scientific OfficerJan 10Option Exercise50.5160030,30625,308Jan 14 05:33 PM
Gregory Philip DChief Scientific OfficerJan 10Sale94.0360056,41624,708Jan 14 05:33 PM
Leschly NickPresident and CEOJan 07Sale89.9710,163914,37756,712Jan 09 05:33 PM
Gregory Philip DChief Scientific OfficerJan 07Sale89.974,134371,94124,708Jan 09 05:33 PM
Davidson DavidChief Medical OfficerJan 07Sale89.973,297296,63528,319Jan 09 05:33 PM
Cole JasonChief Operating andJan 07Sale89.971,957176,07425,049Jan 09 05:33 PM
FINGER ALISON CECILYChief Commercial OfficerJan 07Sale89.971,04994,38018,148Jan 09 05:33 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJan 07Sale89.9722320,0646,308Jan 09 05:33 PM
Smith-Farrell JoanneChief Business OfficerJan 07Sale89.9740836,70811,976Jan 09 05:33 PM
Gregory Philip DChief Scientific OfficerJan 06Sale86.6625021,66528,842Jan 08 05:13 PM
FINGER ALISON CECILYChief Commercial OfficerJan 03Sale84.9651743,92419,197Jan 07 05:02 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerDec 19Sale92.5939736,7586,449Dec 23 05:00 PM
Gregory Philip DChief Scientific OfficerDec 17Option Exercise50.511,80090,91830,892Dec 19 04:54 PM
Gregory Philip DChief Scientific OfficerDec 17Sale94.311,800169,74929,092Dec 19 04:54 PM
Gregory Philip DChief Scientific OfficerDec 05Sale80.5725020,14329,092Dec 09 05:01 PM